13F-HR filed by Foresite Capital Management V, LLC
Foresite Capital Management V, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:24:20 UTC, with 9 holding rows worth $289,147,716.
- Accession
- 0001104659-26-128380
- Filer
- CIK 1792206
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 9 entries on the cover page, a total value of $289,147,716 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,147,716 with VALUE read as dollars as filed, 13F file number 028-20850. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,079,050 | $76,493,855 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 3,562,984 | $59,501,833 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 5,896,995 | $43,578,793 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 883,751 | $26,326,942 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 374,069 | $24,486,557 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 664,142 | $21,066,584 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 729,602 | $16,211,756 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 458,742 | $10,876,773 | dollars as filed | |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 1,318,983 | $10,604,623 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-128380 | this filing | 2026-11-16 |